Ilika to host Capital Markets Day on 23 April 2024

Ilika plc

Ilika plc (LON:IKA), a pioneer in solid-state battery technology, has announced that the Company will be hosting a Capital Markets Day on the morning of Tuesday 23 April 2024 from 09.00 to 13.00 BST.

The event will be an opportunity to learn more about Ilika and its product portfolio, recent progress, financials and outlook. The team will also provide commentary on market trends and the broader opportunity, with participation from the management team as well as clients, collaborators and external speakers discussing the solid-state battery space.

Analysts and institutional investors are welcome to attend the event in the City of London and should contact [email protected] in order to register their interest.

We’ll keep you in the loop!

Join 1,000's of investors who read our articles first

We don’t spam! Read our privacy policy for more info.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Ilika’s Stereax batteries set for Medical Technology Ireland showcase

Ilika’s Stereax batteries will be showcased by Cirtec Medical at Medical Technology Ireland, giving the company targeted exposure in the medical device market.

Ilika CEO Graeme Purdy discusses Stereax revenues and Goliath opportunities

Ilika CEO Graeme Purdy discusses first Stereax revenues, grant support for Goliath, EV market trends, and opportunities in defence and e-bikes.

Ilika positions solid state batteries for the future of implantable neurostimulation

Ilika’s Stereax solid state battery technology supports the development of smaller, safer and more practical implantable neurostimulation devices for emerging medical applications.

Ilika advances manufacturing readiness for solid-state batteries

Ilika’s collaboration with UKBIC shows how manufacturing validation is helping move its Goliath pouch cell technology closer to commercial readiness.

Ilika reports first Stereax revenues and Goliath progress

Ilika expects FY26 revenue of approximately ÂŁ1.1m, including first commercial Stereax electrode sales, with Goliath evaluation activity expanding across automotive, defence and e-bike applications.

Search